Vishal Bhatnagar, MD

Vishal Bhatnagar is a medical oncologist and Associate Director of Oncology Patient Outcomes at the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration. His clinical focus is in multiple myeloma. Prior to his time in OCE, he was a primary reviewer and team leader in the Division of Hematology Products (DHP), where he reviewed myeloma product applications and advised sponsors on efficient drug development. His current regulatory work focuses on management of the OCE’s patient-focused drug development program. His interests include patient-reported outcomes, patient preference, and incorporation of patient experience in oncology trials. Dr. Bhatnagar received his B.A. in Political Science and his M.D. at the George Washington University. He completed his internal medicine residency and hematology/oncology fellowship at the University of Maryland.